INTRAVENOUS ORAL CIPROFLOXACIN VERSUS INTRAVENOUS CEFTAZIDIME IN THE TREATMENT OF SERIOUS GRAM-NEGATIVE INFECTIONS OF THE SKIN AND SKIN STRUCTURE

被引：29

作者：

GENTRY, LO ^{[1
]}

KOSHDEL, A ^{[1
]}

机构：

[1] BAYLOR UNIV,HOUSTON,TX 77030

来源：

AMERICAN JOURNAL OF MEDICINE | 1989年 / 87卷 / 5A期

关键词：

D O I：

10.1016/0002-9343(89)90042-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S132 / S135

页数：4

共 8 条

[1] CIPROFLOXACIN, A QUINOLONE CARBOXYLIC-ACID COMPOUND ACTIVE AGAINST AEROBIC AND ANAEROBIC-BACTERIA [J].

CHIN, NX ;

NEU, HC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) :319-326

[2] PHARMACOKINETICS AND TISSUE PENETRATION OF CIPROFLOXACIN [J].

CRUMP, B ;

WISE, R ;

DENT, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) :784-786

[3] INVITRO ACTIVITY OF CIPROFLOXACIN (BAY O 9867) [J].

FASS, RJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (04) :568-574

[4]

GENTRY LO, 1985, AM J MED, V79, P64

[5] MULTIPLE-DOSE PHARMACOKINETICS AND SAFETY OF CIPROFLOXACIN IN NORMAL VOLUNTEERS [J].

GONZALEZ, MA ;

URIBE, F ;

MOISEN, SD ;

FUSTER, AP ;

SELEN, A ;

WELLING, PG ;

PAINTER, B .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (05) :741-744

[6] TREATMENT OF BONE, JOINT, AND SOFT-TISSUE INFECTIONS WITH ORAL CIPROFLOXACIN [J].

GREENBERG, RN ;

KENNEDY, DJ ;

REILLY, PM ;

LUPPEN, KL ;

WEINANDT, WJ ;

BOLLINGER, MR ;

AGUIRRE, F ;

KODESCH, F ;

SAEED, AMK .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (02) :151-155

[7]

THADEPALLI H, 1988, REV INFECT DIS, V10, P505

[8] INVITRO ACTIVITY OF BAY-09867, A NEW QUINOLINE DERIVATIVE, COMPARED WITH THOSE OF OTHER ANTI-MICROBIAL AGENTS [J].

WISE, R ;

ANDREWS, JM ;

EDWARDS, LJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (04) :559-564

← 1 →